![Thomas Borén](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Borén
Corporate Officer/Principal chez Umea Universitet
Postes actifs de Thomas Borén
Sociétés | Poste | Début | Fin |
---|---|---|---|
Umea Universitet | Corporate Officer/Principal | - | - |
Historique de carrière de Thomas Borén
Anciens postes connus de Thomas Borén
Sociétés | Poste | Début | Fin |
---|---|---|---|
Helicure AB
![]() Helicure AB Pharmaceuticals: MajorHealth Technology Helicure AB develops and manufactures vaccines. It operates as a biotech company that focuses on developing vaccines for prevention of gastric cancer caused by Helicobacter pylori, through active immunisation in infected patients with persistent dyspepsia. The company was founded by Thomas Borén and Lennart Hammarström in 2005 and is headquartered in Umea, Sweden. | Directeur/Membre du Conseil | 17/05/2011 | - |
Directeur Général | 01/01/2005 | - | |
Directeur Technique/Scientifique/R&D | 16/05/2011 | - | |
Fondateur | 01/01/2005 | - |
Statistiques
Internationale
Suède | 3 |
Opérationnelle
Corporate Officer/Principal | 1 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectorielle
Consumer Services | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Helicure AB
![]() Helicure AB Pharmaceuticals: MajorHealth Technology Helicure AB develops and manufactures vaccines. It operates as a biotech company that focuses on developing vaccines for prevention of gastric cancer caused by Helicobacter pylori, through active immunisation in infected patients with persistent dyspepsia. The company was founded by Thomas Borén and Lennart Hammarström in 2005 and is headquartered in Umea, Sweden. | Health Technology |
- Bourse
- Insiders
- Thomas Borén
- Expérience